|
1
|
Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis.
|
J Infect Dis
|
2004
|
5.93
|
|
2
|
Pregnancy and infection.
|
N Engl J Med
|
2014
|
4.15
|
|
3
|
Reduced lopinavir exposure during pregnancy.
|
AIDS
|
2006
|
3.98
|
|
4
|
Adherence to antiretrovirals among US women during and after pregnancy.
|
J Acquir Immune Defic Syndr
|
2008
|
2.38
|
|
5
|
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
|
MMWR Recomm Rep
|
2009
|
2.31
|
|
6
|
Diagnosis of HIV-1 infection in children younger than 18 months in the United States.
|
Pediatrics
|
2007
|
2.08
|
|
7
|
Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania.
|
Pediatr Infect Dis J
|
2008
|
2.00
|
|
8
|
Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
|
AIDS
|
2006
|
1.99
|
|
9
|
A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission.
|
AIDS
|
2006
|
1.96
|
|
10
|
Early immunological predictors of neurodevelopmental outcomes in HIV-infected children.
|
Clin Infect Dis
|
2009
|
1.68
|
|
11
|
Lopinavir exposure with an increased dose during pregnancy.
|
J Acquir Immune Defic Syndr
|
2008
|
1.65
|
|
12
|
Breast-feeding and Transmission of HIV-1.
|
J Acquir Immune Defic Syndr
|
2004
|
1.56
|
|
13
|
Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes.
|
J Acquir Immune Defic Syndr
|
2011
|
1.55
|
|
14
|
Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study.
|
Pediatrics
|
2007
|
1.51
|
|
15
|
Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024.
|
AIDS
|
2005
|
1.49
|
|
16
|
Predictors of repeat pregnancy among HIV-1-infected women.
|
J Acquir Immune Defic Syndr
|
2007
|
1.48
|
|
17
|
Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. American Academy of Pediatrics Committee on Pediatric AIDS.
|
Pediatrics
|
2003
|
1.41
|
|
18
|
The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth.
|
Am J Obstet Gynecol
|
2006
|
1.37
|
|
19
|
Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.
|
J Acquir Immune Defic Syndr
|
2010
|
1.35
|
|
20
|
Lopinavir tablet pharmacokinetics with an increased dose during pregnancy.
|
J Acquir Immune Defic Syndr
|
2010
|
1.33
|
|
21
|
Interventions for preventing late postnatal mother-to-child transmission of HIV.
|
Cochrane Database Syst Rev
|
2009
|
1.29
|
|
22
|
In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.
|
AIDS Patient Care STDS
|
2011
|
1.26
|
|
23
|
Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis.
|
AIDS Behav
|
2010
|
1.26
|
|
24
|
Atazanavir pharmacokinetics with and without tenofovir during pregnancy.
|
J Acquir Immune Defic Syndr
|
2011
|
1.24
|
|
25
|
Antiretroviral adherence during pregnancy and postpartum in Latin America.
|
AIDS Patient Care STDS
|
2012
|
1.20
|
|
26
|
A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers.
|
Am J Epidemiol
|
2012
|
1.17
|
|
27
|
HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers.
|
AIDS
|
2006
|
1.15
|
|
28
|
Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia.
|
Sex Transm Dis
|
2006
|
1.13
|
|
29
|
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.
|
J Infect Dis
|
2003
|
1.11
|
|
30
|
Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study.
|
J Acquir Immune Defic Syndr
|
2010
|
1.10
|
|
31
|
Predictors of stillbirth in sub-saharan Africa.
|
Obstet Gynecol
|
2007
|
1.10
|
|
32
|
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.
|
Pediatr Infect Dis J
|
2012
|
1.06
|
|
33
|
Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children.
|
J Acquir Immune Defic Syndr
|
2010
|
1.05
|
|
34
|
Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study.
|
Pediatr Infect Dis J
|
2005
|
1.04
|
|
35
|
Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
|
AIDS
|
2007
|
1.04
|
|
36
|
Mode of delivery and postpartum morbidity in Latin American and Caribbean countries among women who are infected with human immunodeficiency virus-1: the NICHD International Site Development Initiative (NISDI) Perinatal Study.
|
Am J Obstet Gynecol
|
2006
|
1.04
|
|
37
|
Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women.
|
Am J Clin Nutr
|
2008
|
1.04
|
|
38
|
Participation of HIV-infected pregnant women in research in the United States.
|
AIDS Res Hum Retroviruses
|
2007
|
1.02
|
|
39
|
Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms.
|
J Acquir Immune Defic Syndr
|
2004
|
1.01
|
|
40
|
HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population.
|
Am J Obstet Gynecol
|
2006
|
1.00
|
|
41
|
Pregnancy and infection.
|
N Engl J Med
|
2014
|
0.99
|
|
42
|
Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: plasma versus PBMCs.
|
AIDS Res Hum Retroviruses
|
2008
|
0.98
|
|
43
|
Tolerance and safety of different concentrations of chlorhexidine for peripartum vaginal and infant washes: HIVNET 025.
|
J Acquir Immune Defic Syndr
|
2004
|
0.98
|
|
44
|
Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.
|
J Infect Dis
|
2005
|
0.98
|
|
45
|
Update: Ongoing Zika Virus Transmission - Puerto Rico, November 1, 2015-July 7, 2016.
|
MMWR Morb Mortal Wkly Rep
|
2016
|
0.98
|
|
46
|
Maternal neutralizing antibody and transmission of hepatitis C virus to infants.
|
J Infect Dis
|
2008
|
0.97
|
|
47
|
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.
|
Pediatr Infect Dis J
|
2010
|
0.97
|
|
48
|
Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants.
|
Int J Infect Dis
|
2010
|
0.97
|
|
49
|
Impact of pregnancy on abacavir pharmacokinetics.
|
AIDS
|
2006
|
0.95
|
|
50
|
Maternal antiretrovirals and hepatic enzyme, hematologic abnormalities among human immunodeficiency virus type 1-uninfected infants: the NISDI perinatal study.
|
Pediatr Infect Dis J
|
2007
|
0.95
|
|
51
|
Relationship between mortality and feeding modality among children born to HIV-infected mothers in a research setting: the Kesho Bora study.
|
AIDS
|
2013
|
0.95
|
|
52
|
Analysis of HIV type 1 diversity in pregnant women from four Latin American and Caribbean countries.
|
AIDS Res Hum Retroviruses
|
2006
|
0.94
|
|
53
|
Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Latin America and the Caribbean: the NISDI perinatal study.
|
Pediatr Infect Dis J
|
2007
|
0.92
|
|
54
|
Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa.
|
Pediatrics
|
2009
|
0.92
|
|
55
|
Postpartum changes in plasma viral load and CD4 percentage among HIV-infected women from Latin American and Caribbean countries: the NISDI Perinatal Study.
|
Mem Inst Oswaldo Cruz
|
2011
|
0.92
|
|
56
|
Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study.
|
J Infect Dis
|
2004
|
0.91
|
|
57
|
Incidence of Zika Virus Disease by Age and Sex - Puerto Rico, November 1, 2015-October 20, 2016.
|
MMWR Morb Mortal Wkly Rep
|
2016
|
0.90
|
|
58
|
Knowledge and practice of prechewing/prewarming food by HIV-infected women.
|
Pediatrics
|
2011
|
0.89
|
|
59
|
Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol.
|
BMC Pediatr
|
2009
|
0.88
|
|
60
|
CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption.
|
J Acquir Immune Defic Syndr
|
2011
|
0.88
|
|
61
|
CD4/CD8 T-cell ratio predicts HIV infection in infants: the National Heart, Lung, and Blood Institute P2C2 Study.
|
J Allergy Clin Immunol
|
2007
|
0.88
|
|
62
|
Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy.
|
J Infect Dis
|
2008
|
0.88
|
|
63
|
Postpartum weight change among HIV-infected mothers by antiretroviral prophylaxis and infant feeding modality in a research setting.
|
AIDS
|
2014
|
0.88
|
|
64
|
Placental malaria and mother-to-child transmission of human immunodeficiency virus-1.
|
Am J Trop Med Hyg
|
2009
|
0.87
|
|
65
|
CD4+/CD8+ T cell ratio for diagnosis of HIV-1 infection in infants: Women and Infants Transmission Study.
|
Pediatrics
|
2008
|
0.87
|
|
66
|
Research on vaccines during pregnancy: protocol design and assessment of safety.
|
Vaccine
|
2013
|
0.87
|
|
67
|
Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments.
|
Vaccine
|
2013
|
0.86
|
|
68
|
Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment.
|
J Acquir Immune Defic Syndr
|
2009
|
0.85
|
|
69
|
Changes in sexual behaviour among HIV-infected women in west and east Africa in the first 24 months after delivery.
|
AIDS
|
2012
|
0.84
|
|
70
|
Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in sub-Saharan Africa.
|
Pediatr Infect Dis J
|
2008
|
0.84
|
|
71
|
Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings.
|
Vaccine
|
2012
|
0.84
|
|
72
|
Population attributable fractions for late postnatal mother-to-child transmission of HIV-1 in Sub-Saharan Africa.
|
J Acquir Immune Defic Syndr
|
2010
|
0.84
|
|
73
|
Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and Zambia.
|
Int J Gynaecol Obstet
|
2009
|
0.83
|
|
74
|
The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
|
Pediatrics
|
2005
|
0.83
|
|
75
|
Antiretroviral interventions for preventing breast milk transmission of HIV.
|
Cochrane Database Syst Rev
|
2014
|
0.83
|
|
76
|
Prevention of mother-to-child transmission of HIV-1: the role of cesarean delivery.
|
Clin Perinatol
|
2010
|
0.83
|
|
77
|
Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
|
Pediatr Infect Dis J
|
2011
|
0.83
|
|
78
|
Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth.
|
S Afr Med J
|
2010
|
0.81
|
|
79
|
Progress in overcoming barriers to influenza immunization of pregnant women.
|
Am J Obstet Gynecol
|
2012
|
0.81
|
|
80
|
Infant feeding modes and determinants among HIV-1-infected African Women in the Kesho Bora Study.
|
J Acquir Immune Defic Syndr
|
2013
|
0.81
|
|
81
|
Laboratory abnormalities among HIV-1-infected pregnant women receiving antiretrovirals in Latin America and the Caribbean.
|
AIDS Patient Care STDS
|
2008
|
0.81
|
|
82
|
Early infant feeding patterns and HIV-free survival: findings from the Kesho-Bora trial (Burkina Faso, Kenya, South Africa).
|
Pediatr Infect Dis J
|
2015
|
0.81
|
|
83
|
Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants.
|
J Acquir Immune Defic Syndr
|
2010
|
0.80
|
|
84
|
Antiretroviral use during pregnancy for treatment or prophylaxis.
|
Expert Opin Pharmacother
|
2011
|
0.80
|
|
85
|
T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines.
|
AIDS Res Hum Retroviruses
|
2010
|
0.80
|
|
86
|
Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission Study.
|
AIDS
|
2006
|
0.79
|
|
87
|
Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected women.
|
Obstet Gynecol
|
2010
|
0.79
|
|
88
|
Association of Body Mass Index of HIV-1-Infected Pregnant Women and Infant Weight, Body Mass Index, Length, and Head Circumference: The NISDI Perinatal Study.
|
Nutr Res
|
2007
|
0.79
|
|
89
|
Trends in the management and outcome of HIV-1-infected women and their infants in the NISDI Perinatal and LILAC cohorts, 2002-2009.
|
Int J Gynaecol Obstet
|
2013
|
0.79
|
|
90
|
Cesarean delivery for HIV-infected women: recommendations and controversies.
|
Am J Obstet Gynecol
|
2007
|
0.77
|
|
91
|
Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period.
|
AIDS
|
2008
|
0.76
|
|
92
|
Prevention of HIV transmission through breast-feeding: strengthening the research agenda.
|
J Acquir Immune Defic Syndr
|
2004
|
0.76
|
|
93
|
Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States.
|
Pediatrics
|
2017
|
0.76
|
|
94
|
Institutional prevention policies and rates of Group B Streptococcus infection among HIV-infected pregnant women and their infants in Latin America.
|
Int J Gynaecol Obstet
|
2012
|
0.75
|
|
95
|
Prechewing and prewarming food for HIV-exposed children: a prospective cohort experience from Latin America.
|
AIDS Patient Care STDS
|
2013
|
0.75
|
|
96
|
Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery.
|
J Acquir Immune Defic Syndr
|
2013
|
0.75
|
|
97
|
Adherence to antiretroviral prophylaxis during early infancy in Latin America.
|
Braz J Infect Dis
|
2013
|
0.75
|
|
98
|
Mode of delivery and neonatal respiratory morbidity among HIV-exposed newborns in Latin America and the Caribbean: NISDI Perinatal-LILAC Studies.
|
Int J Gynaecol Obstet
|
2011
|
0.75
|
|
99
|
Excess respiratory viral infections and low antibody responses among HIV-exposed, uninfected infants.
|
AIDS
|
2017
|
0.75
|
|
100
|
Fetal fibronectin and adverse infant outcomes in a predominantly human immunodeficiency virus-infected African population: a randomized controlled trial.
|
Obstet Gynecol
|
2007
|
0.75
|
|
101
|
Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus.
|
Obstet Gynecol
|
2017
|
0.75
|